How Much does Cancer Immunotherapy Cost?
Medically reviewed by Prof. Shimon Slavin, MD. Updated: May 2026
The cost of cancer immunotherapy depends on the diagnosis, the stage of the disease, the complexity of the protocol, and the methods used. The price of approved immunotherapy drugs is usually known in advance and may be partially covered by national health systems or insurance plans. Advanced immunotherapy programs typically combine modern diagnostic and treatment methods, anti-cancer medications, and personalized therapeutic approaches tailored to each patient.
Many international patients seek personalized immunotherapy after standard treatment options have been exhausted or when specific protocols are unavailable in their home country. The staged structure of treatment, transparent pricing, and the ability to complete part of the diagnostic workup locally help patients plan treatment abroad more effectively.
What factors influence the cost of cancer immunotherapy?
Every immunotherapy program is developed individually based on a medical review of the patient’s case. Therefore, the final price depends on several clinically important factors, listed below in the order in which they are usually considered, from the initial assessment of the case to the practical details of the treatment protocol.
- Diagnosis and molecular profile of the tumor. The type of tumor, how far it has spread, and the results of immunohistochemical analysis determine which methods may be included in the protocol.
- General condition of the patient. The severity of the patient’s condition and tolerance to treatment influence which treatment methods can be used, and whether individual procedures can be performed on an outpatient basis or will require hospitalization.
- Scope of the diagnostic workup. The amount of molecular and laboratory testing required (tumor marker analysis, circulating free DNA testing, circulating tumor cells testing) is determined for each patient based on the data already available.
- Method of drug administration. Before treatment begins, imaging is performed to assess whether direct administration of medications into the tumor is feasible.
- Phased structure of the program. Treatment is built in several stages: systemic therapy to reduce tumor burden, combined immunotherapy with standard anti-cancer drugs and anti-angiogenic therapy, and, in case of a positive response, transition to more intensive experimental cell-mediated immunotherapy. The cost of each stage is calculated separately.
- Treatment duration, number of cycles, and patient’s body weight. The core in-clinic course lasts 14 days, after which treatment may continue with additional immunotherapy and anti-angiogenic therapy over several months. The number of cycles and medication dosages are calculated according to the patient’s body weight, which directly affects the final cost estimate.
Cost of Cancer Immunotherapy in Germany
Advanced personalized cancer immunotherapy is available at only a limited number of specialized centers worldwide. The cost of treatment can vary considerably depending on the specific methods used, laboratory requirements, treatment duration, and the degree of personalization involved.
At Biotherapy International, treatment is provided through the organization’s partner clinic in Rheinfelden, Germany according to an individualized medical plan developed for each patient. Every protocol is based on a comprehensive review of the diagnosis, treatment history, tumor characteristics, molecular findings, and overall clinical condition.
To provide greater transparency and flexibility, treatment costs are calculated by individual components and stages rather than as a single fixed package. This approach allows patients to understand exactly what is included in their program and plan their treatment budget step by step.
Core treatment components
| Component | Indicative cost (EUR) |
|---|---|
| Oncolytic virus therapy course (14-day in-clinic course) | from €48,000 |
| Anti-cancer vaccine made from the patient’s own tumor | from €50,000 |
| Photodynamic therapy (PDT) | from €3,000 |
Why personalized immunotherapy programs are more expensive than standard treatments
Unlike standard chemotherapy, many personalized immunotherapy methods require individual production of biological components, detailed molecular profiling, and complex laboratory preparation tailored to a single patient. These additional processes significantly increase the cost compared to standardized treatment regimens.
Pre-treatment diagnostic workup
When needed, the clinic can arrange advanced molecular and laboratory testing before treatment begins. The treatment protocol is developed after a medical review of the case, based on the patient’s diagnosis, treatment history, imaging data, and molecular findings.
| Test | Indicative cost (EUR) |
|---|---|
| Tumor marker and molecular profiling panel | from €6,000 |
| Circulating free DNA (cfDNA) test, monitoring tumor-derived DNA from a venous blood sample | from €4,000 |
| Circulating tumor cells (CTC) test | from €1,000 |
A detailed individual cost estimate is provided after a medical review of the patient’s case by the Biotherapy International medical team.
Ready to find out the estimated cost of your immunotherapy program?
The cost of your program depends on your diagnosis, treatment history, and the treatment methods included in your personalized protocol. After reviewing your case, our team can prepare a preliminary cost estimate for you.
What is included in the core course and what is billed separately
The core oncolytic virus therapy course covers the medical procedures performed within the 14-day oncolytic virus protocol, together with the medications included in the protocol.
The following components of the program are usually billed separately:
- immunotherapy following the core course (checkpoint inhibitors, cytokine-mediated immunotherapy), with the cost depending on the patient’s body weight and the number of cycles;
- anti-angiogenic therapy, with one of several possible medications selected for the protocol;
- diagnostic studies: immunohistochemical tumor marker analysis, cfDNA testing, circulating tumor cells (CTC) testing;
- imaging: MRI, CT, or PET-CT;
- laboratory blood tests;
- clinic service fees for intravenous infusions performed outside the oncolytic virus protocol;
- accommodation and airfare;
- international logistics and shipment of biological samples, when applicable.
Some patients can complete part of the diagnostic workup and laboratory testing locally before traveling for treatment, which helps reduce the overall cost of the program.
Does insurance cover cancer immunotherapy?
Insurance coverage depends on the type of immunotherapy and the way the treatment is delivered. Approved immunotherapy drugs may be covered by insurance when they are prescribed by the patient’s local oncologist and obtained through official pharmacy channels.
Personalized and experimental immunotherapy programs generally fall outside standard clinical guidelines and, as a rule, are not covered by insurance providers.
In some cases, patients who begin treatment abroad continue with selected approved components of the protocol through their local oncologist after returning home. Depending on the terms of the insurance policy and the regulations in the patient’s country of residence, certain medications may be eligible for partial reimbursement.
Get an individual cost estimate for your case
Every cancer case is unique, and so are the treatment program and its cost. To prepare a preliminary medical estimate, our team needs to review the patient’s diagnosis, prior treatment history, and the most recent imaging results.
FAQ
A full advanced immunotherapy program is built from several components, each priced separately. At our partner clinic in Germany, the core oncolytic virus therapy course starts from €48,000, with components such as additional immunotherapy, anti-angiogenic therapy, diagnostic testing, and tumor microenvironment modulation calculated individually based on the patient's protocol.
